NASDAQ ยท Healthcare ยท Drug Manufacturers - General
Market Cap$158.77B
Sector
Healthcare
IndustryDrug Manufacturers - General
52-Week Low$107.75
52-Week High$157.29
CEODaniel O'Day
IPO DateJan 22, 1992
Employees17,600
CountryUnited States
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs.